Watchlist Price Alert

Citius Oncology Inc. (CTOR)

NASDAQ: CTOR · Real-Time Price · USD

0.85

-0.03 (-3.41%)

May 06, 2025, 11:03 AM - Market open

Citius Oncology Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022
Net Income	-21.15M	-12.7M	-5.43M
Depreciation & Amortization	n/a	n/a	n/a
Stock-Based Compensation	7.5M	1.97M	n/a
Other Working Capital	10.78M	8.61M	4.74M
Other Non-Cash Items	n/a	n/a	n/a
Deferred Income Tax	576K	576K	576K
Change in Working Capital	13.2M	10.16M	4.86M
Operating Cash Flow	126.35K	n/a	n/a
Capital Expenditures	-5M	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a
Other Investing Acitivies	-5M	n/a	n/a
Investing Cash Flow	-5M	n/a	n/a
Debt Repayment	3.8M	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a
Other Financial Acitivies	1.07M	n/a	n/a
Financial Cash Flow	4.87M	n/a	n/a
Net Cash Flow	112.00	n/a	n/a
Free Cash Flow	-4.87M	n/a	n/a